Animal models provide a useful platform for developing and testing new drugs to treat liver fibrosis. Accordingly, we developed a novel automated system to evaluate liver fibrosis in rodent models. This system uses second-harmonic generation (SHG)/two-photon excited fluorescence (TPEF) microscopy to assess a total of four mouse and rat models, using chemical treatment with either thioacetamide (TAA) or carbon tetrachloride (CCl 4 ), and a surgical method, bile duct ligation (BDL). The results obtained by the new technique were compared with that using Ishak fibrosis scores and two currently used quantitative methods for determining liver fibrosis: the collagen proportionate area (CPA) and measurement of hydroxyproline (HYP) content. We show that 11 shared morphological parameters faithfully recapitulate Ishak fibrosis scores in the models, with high area under the receiver operating characteristic (ROC) curve (AUC) performance. The AUC values of 11 shared parameters were greater than that of the CPA (TAA: 0.758-0.922 vs 0.752-0.908; BDL: 0.874-0.989 vs 0.678-0.966) in the TAA mice and BDL rat models and similar to that of the CPA in the TAA rat and CCl 4 mouse models. Similarly, based on the trends in these parameters at different time points, 9, 10, 7, and 2 modelspecific parameters were selected for the TAA rats, TAA mice, CCl 4 mice, and BDL rats, respectively. These parameters identified differences among the time points in the four models, with high AUC accuracy, and the corresponding AUC values of these parameters were greater compared with those of the CPA in the TAA rat and mouse models (rats: 0.769-0.894 vs 0.64-0.799; mice: 0.87-0.93 vs 0.739-0.836) and similar to those of the CPA in the CCl 4 mouse and BDL rat models. Similarly, the AUC values of 11 shared parameters and model-specific parameters were greater than those of HYP in the TAA rats, TAA mice, and CCl 4 mouse models and were similar to those of HYP in the BDL rat models. The automated evaluation system, combined with 11 shared parameters and model-specific parameters, could specifically, accurately, and quantitatively stage liver fibrosis in animal models.
Liver fibrosis is the eventual outcome of many chronic liver diseases, regardless of the etiology of injury. Fibrosis results from an imbalance in the normal wound-healing response, generating an abnormal continuation of fibrogenesis, that is, connective tissue production and deposition. Liver fibrosis and its end-stage outcomes, cirrhosis or hepatocellular carcinoma, represent a serious global health-care burden. 1, 2 While anti-viral treatments are able to inhibit fibrosis in both chronic hepatitis B (CHB) and chronic hepatitis C (CHC) patients, the disease does not regress. There are also no effective treatments for liver fibrosis that is not caused by infectious agents, such as non-alcoholic steatohepatitis. 3 Therefore, pharmacological therapies that prevent the progression toward cirrhosis or induce regression of advanced fibrosis and cirrhosis are urgently needed. 4, 5 Because many factors complicate studies of liver fibrosis in human subjects, rodent models of liver fibrosis that mimic human liver diseases have been developed and used for several decades to study fibrogenesis. These models provide a useful platform for developing novel antifibrotic therapeutic approaches and testing new drugs. 6, 7 However, an appropriate staging system (such as Ishak) or other quantitative methods for examining liver fibrosis (measurement of the collagen proportional area (CPA) or hydroxyproline (HYP) content) have not been extensively studies in animal models. Therefore, the precise, accurate, and dynamic evaluation of the degree of liver fibrosis in animal models would be very valuable for the development of more effective drugs.
Second-harmonic generation (SHG) is a very sensitive method used to detect dissymmetry in structures and is suitable for imaging collagen fibers with noncentrosymmetric structures. Organizational structures and autofluorescence properties are observed using two-photon excited fluorescence (TPEF) imaging when the sample is irradiated with an exogenous or endogenous laser.
SHG/TPEF has been successfully used to assess fibrosis in various tissues and organs, including the liver. Compared with traditional staining, such as Masson's trichrome and Sirius red staining, SHG/TPEF is a sensitive, quantitative, and automated tool that characterizes collagen in fibrotic tissues. [8] [9] [10] [11] A series of automated assessment methods combining the quantification of histopathological architectural parameters imaged using SHG/TPEF was reported as useful in core biopsy evaluations of fibrosis in CHB and CHC patients. [12] [13] [14] [15] However, it is not clear whether this purely quantitative method can be used to evaluate liver fibrosis models.
When evaluating the process of fibrogenesis, the results should be replicable in a minimum of two models using different fibrosis-inducing stimuli. Therefore, the main aim of this study was to develop an automated evaluation system for liver fibrosis by combining SHG microscopy and the adaptive quantification algorithm to identify collagen progression patterns that are shared by or specific to three different fibrotic animal models. With the aim of increasing the diagnostic precision compared with the available liver fibrosis staging methods, the results were compared with the CPA method.
MATERIALS AND METHODS Ethics Statement
The care and use of animals completely complied with the relevant governmental and institutional policies. All animals were supplied by Beijing Vital River Laboratory Animal Technology, China. The animals were housed at 25°C with a 12 h light-dark cycle and provided standard chow and water ad libitum until the time of the study. All study protocols were approved by the Animal Experimental Ethical Committee of Peking University People's Hospital (No. 2014-23) .
Animal Models of Liver Fibrosis TAA Rat and Mouse Models Male Wistar rats weighing 200-250 g were intoxicated with thioacetamide (TAA) (Sigma, St Louis, MO, USA) for 18 weeks. Initially, 0.03% TAA was administered to all groups via the drinking water. Thereafter, the TAA concentrations were adapted weekly according to the body weight, aiming to maintain individual body weights between the preset limits of 200 and 250 g, as described previously. 16 Practically, the TAA concentrations were increased or decreased by 50% if the weight increased or decreased more than 20 g weekly or if the overall weight increased or decreased more than 60 g. The rats were killed at 2, 4, 6, 8, 12, 16, and 18 weeks (n = 12 per week) using sodium pentobarbital. Ten control rats were also used at week 0 after the experiment was initiated.
Six-eight-week-old male C57Bl/6 mice were exposed to TAA (Sigma) dissolved in drinking water (300 mg/l) for 18 weeks to induce hepatic fibrosis, whereas the controls received an equal volume of water. The mice were killed at 2, 4, 6, 8, 12, 16, and 18 weeks (n = 8 per week) using sodium pentobarbital. Six control mice were also used at week 0 after the experiment was initiated.
CCl 4 Mouse Model
Six-week-old male BALB/c mice were intraperitoneally injected with carbon tetrachloride (CCl 4 ) (1 ml/kg BW dissolved in olive oil; final concentration of 10%) twice per week for 16 weeks to induce liver fibrosis. The mice were killed at 1, 2, 4, 6, 8, 12, and 16 weeks (n = 8 per week) using sodium pentobarbital. Six control mice were also used at week 0 after the experiment was initiated.
BDL Rat Model
Bile duct ligation (BDL)-induced fibrosis was initiated as described previously. 17 Liver fibrosis was induced in age-matched male Sprague-Dawley rats (250-300 g) using BDL under isoflurane anesthesia. This procedure generates a successful ligation. The bile duct was similarly manipulated but not ligated in the SHAM rats. The rats were killed at 1, 2, 3, 4, and 5 weeks (n = 12 per week) using sodium pentobarbital. Ten control rats were also killed at week 0.
All animals were anesthetized and blood was collected at the time of killing to measure the serum alanine aminotransferase (ALT) and γ-glutamyl transpeptidase (GGT) levels. Liver specimens from the left lateral lobe of each animal were formalin-fixed, paraffin-embedded, and sectioned for direct SHG imaging, hematoxylin and eosin, Masson's trichrome, or picrosirius red staining (PS) for histological analysis. Inflammatory activities and fibrosis were semiquantitatively evaluated by pathologists using the Ishak scoring system. 18 The remaining portion of the liver was frozen in liquid nitrogen and stored at − 80°C until the HYP content was determined.
In the toxin treatment models, including the TAA Wistar rats, TAA mice, and CCl 4 mouse models, samples were collected for further analysis at five time points, including the untreated animals at week 0 and the treated animals at weeks 4, 8, 12 and 16, and samples were collected from the BDL rat 
Determination of the HYP Content
The extent of the liver fibrosis was also determined by estimating the total liver collagen content, as reflected by measurements of the HYP content in the liver. HYP content was measured using a test kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). Briefly, the liver tissue samples were weighed and hydrolyzed with NaOH to release HYP from collagen. Next, HYP was oxidized with chloramine T, followed by a reaction with paradimethylaminobenzaldehyde at 65°C to develop a mauve color. The absorbance was measured at 550 nm, and the HYP concentration was calculated by comparing the value with standards. 19 Image Acquisition System Images of unstained sections of the tissue samples were acquired using a Genesis (HistoIndex, Singapore, Singapore) system. SHG microscopy was used to visualize collagen, and the other cell structures were visualized with TPEF microscopy. The samples were excited with a 780 nm laser, the SHG signals were recorded at 390 nm, and the TPEF signals were recorded at 550 nm. The images were acquired at × 20 magnification with 512 × 512 pixel resolution, and each image had a dimension of 200 × 200 μm 
Image Quantification
The total collagen percentages and other previously reported collagen parameters, 12 including specific string and collagen connectivity-related measurements, were used to assess fibrosis progression in the various animal models and were correlated with the corresponding Ishak fibrosis stages.
One hundred collagen morphological parameters were used in this study (Supplementary Table 1 ). In addition to measuring the CPA as a single parameter, collagen further subcategorized into two different groups, namely, distributed collagen (fine collagen) and aggregated collagen (large patches). 10 In this study, we also implemented liver-specific collagen features including portal collagen (portal expansion), septal collagen (bridging fibrosis), and fibrillar collagen (fine collagen distributed in the pericellular/perisinusoidal space).
Model Construction and Statistical Analysis
The support vector machine (SVM) model method was used to compare the Ishak fibrosis stage and the time point after modeling in each sample with the morphometric collagen features extracted from the images. A hyperplane was constructed to classify optimally the fibrosis stages or modeling time points for the subjects based on the feature values in the m-dimensional space (m ≥ n). The radial basis function kernel was used as the distance measure between two subject vectors x and x′, that is,
where σ controlled the width of the kernel. 14, 20 The receiver operating characteristic (ROC) curve was used to illustrate the performance of the classifier model, as its discrimination threshold varied. The area under the ROC curve (AUC) was used to illustrate the performance of the classifier model, as its discrimination threshold varied. The advantages of different methods were illustrated by comparing the AUC values among methods using the collagen Table 1 
RESULTS

ALT and GGT Levels and the HAI of Liver Injury
The ALT (IU/l) and GGT (IU/l levels and histological activity indices (HAIs) for all experimental groups are shown in Table 1 . These values delineate the course of liver injury following the establishment of the models listed above. There were significant increases in the ALT levels in the TAA mice, CCl 4 mice, and BDL rat groups compared with the week 0 control (Po0.05), but this increase was not observed in the TAA rat group. A significant increase in the GGT levels was only observed in the BDL rat group compared with the week 0 control (Po0.05), but was not observed in the other groups.
Over time, the HAI increased in all experimental groups, but there were no further increases until 12 weeks in the TAA rats and mice, and until 4 weeks in the BDL rats.
SHG/TPEF vs Conventional Histological Imaging
As the time after chemical treatment (TAA or CCl 4 ) and BDL increased, the microscopic features of the liver changed from normal tissue to fibrosis and cirrhosis. The control mice and rats displayed a normal histology and the lobular architecture was preserved. No cellular damage was present.
TAA model
After 6 weeks of TAA intoxication, PS staining primarily showed stage 2 periportal fibrosis. At 12 weeks, PS staining illustrated fine thread-like fibrosis and the formation of portal-portal and portal-central septa that were mainly described as stage 5 fibrosis. At 16 weeks, fully established stage 6 cirrhosis was present in all animals, along with the formation of portal-central shunts (Figure 1 ).
CCl 4 model
Two weeks after CCl 4 administration, PS staining revealed stage 1 or 2 fibrotic changes in the centrolobular area. Eight weeks after CCl 4 administration, the liver architecture primarily changed to stage 4 and exhibited reversed lobulation, because of the development of centrocentral fibrotic linkages. After 12 weeks, the reversed lobulation was accentuated, along with the development of thin fibrotic centroportal septa in addition to the centrocentral fibrotic linkages. However, after 16 weeks, all mice had homogeneous characteristics reflecting stage 6 cirrhosis (Figure 1) .
BDL model
The enlargement of the portal tracts appeared as early as 1 week after BDL. This enlargement was accompanied by dilation of the bile canaliculi and proliferation of the smaller bile ducts. Periportal fibrosis developed 1 to 3 weeks after BDL induction. After 3 weeks, the periportal alterations were accompanied by fibrotic changes described as Ishak stage 3 that evolved into Ishak stage 5 by 5 weeks after BDL (Figure 1) .
SHG and TPEF microscopy were used to quantify simultaneously the changes in fibrillar collagen during liver fibrosis progression. We observed that fibrillar collagen is correctly detected by the SHG signals in the liver tissue, based on the images of the histological staining in the different animal fibrosis models (Figure 1 ).
Eleven Shared Morphological Parameters that Faithfully Recapitulate Ishak Fibrosis Scores
Liver fibrosis progression was quantified using the SHG/TPEF system by examining the collagen levels and morphology. A list of 100 collagen architectural parameters (Supplementary Table 1 ), categorized into four groups, namely, overall, portal, septal, and fibrillar collagen, were identified through image acquisition and processing and translated into quantitative parameters to understand their relationships with the Ishak stages.
We selected separate parameters for each animal model. Based on their trends with respect to the fibrosis stages and systemic AUC analyses, 36, 18, 35, and 40 parameters were selected for the TAA rats, TAA mice, CCl 4 mice, and BDL rats, respectively (Supplementary Table 2 ). In the TAA rats and mice, more portal collagen parameters were consistently elevated throughout the experiment (NoStrP for all stages, Po0.05) ( Figure 2) ; however, more parameters were focused on the overall, portal, and septal collagen in the CCl 4 mice and BDL rats (StrArea for all stages, Po0.01). These differences may be related to the different treatment mechanisms.
Among all of these parameters, we found that 11 were shared by all models, including SHG, StrArea, NoXlink, NoStrP, NoShortStrP, NoLongStrP, NoThickStrP, NoThickStrPA, StrLengthPA, StrWidthPA, and FibrillarAGG (Table 2) , mainly for portal collagen. The flow chart is shown in Figure 3 . Our experiments show that these 11 parameters faithfully recapitulate the Ishak fibrosis scores.
The Eleven Shared Parameters Exhibit Superior Performance Compared with the CPA and HYP Content in Evaluating Liver Fibrosis
The performance of the shared parameters vs CPA for scoring fibrosis were evaluated using an ROC analysis. In the TAA mouse model, the AUC values of the shared parameters for the detection of different stages were 40.8, whereas the AUC of CPA dropped to 0.6 (stage 0 vs 1, 2, 3, 4, 5, and 6; stages 0 and 1 vs 2, 3, 4, 5, and 6; and stages 0, 1, 2, 3, 4, and 5 vs 6). In (Table 3) . Thus, we revealed that the shared parameters can potentially differentiate the various stages of fibrosis in four different liver fibrosis models.
The Model-Specific Parameters Further Improve the Diagnostic Reliability
In addition to the comparison with the Ishak stages, we also performed a test using different time points after modeling.
Based on their trends with respect to time after modeling and systemic AUC analyses, 12, 20, 9, and 18 parameters were selected for the TAA rats, TAA mice, CCl 4 mice, and BDL rat models, respectively. However, no common parameters were shared by the four models with respect to the stage evaluation. We designed a class-specific ensemble feature selection framework to identify the most important parameters of the extracted parameters, and then 9, 10, 7, and 2 parameters were selected for the TAA rats, TAA mice, CCl 4 mice, and BDL rat models, respectively (Supplementary Table 3 ). Next, using the SVM model, these model-specific parameters were shown to identify differences among all time points in the four different fibrosis models, with high AUC accuracy (AUC: 0.751-0.987, Po0.05) ( Table 4 ).
The performances of the model-specific parameters vs CPA for fibrosis scoring were evaluated with an ROC analysis. The AUC values of the model-specific parameters for the detection of different time points after modeling were maintained at higher values than those of the CPA in the TAA rats and mouse models, and were similar in the CCl 4 mice and BDL rat models. Furthermore, in the BDL rat model, the AUC values of the model-specific parameters were greater than the values obtained for the CPA (0.793 vs 0.411).
The performances of the model-specific parameters vs the HYP content for fibrosis scoring were also evaluated with an ROC analysis. The AUC values of the model-specific parameters for the detection of different time points after (Table 4) . Thus, we showed that the model-specific parameters can potentially differentiate fibrosis at different time points in four different liver fibrosis models.
DISCUSSION
In this study, we successfully acquired SHG and TPEF images from TAA, CCl 4 , and BDL rodent models and established an automated evaluation system that is superior to the Ishak staging scores and CPA evaluation.
We first showed the feasibility of our SHG/TPEF microscopy technique in monitoring liver fibrosis progression in the TAA, CCl 4 , and BDL animal models by comparing this system with the conventional Ishak staging/histopathological scoring system. Based on their trends with respect to the fibrosis stages and systemic AUC analyses, 11 shared parameters were selected and faithfully recapitulated the Ishak scores. The TAA, CCl 4 , and BDL models have traditionally been used as the most widely used experimental models of fibrosis, and the collagen distribution profiles in liver fibrosis are significantly different among these models. 21 However, periportal fibrosis is a common feature of these models, and the results showed that 7 out of 11 parameters (NoStrP, NoShortStrP, NoLongStrP, NoThickStrP, NoThickStrPA, StrLengthPA, and StrWidthPA) were primarily derived from portal collagen. The collagen distribution characteristics and high AUC values suggest that these parameters have more discriminative power for precisely reflecting the dynamics of fibrosis progression in different models, and we may be able to identify the patterns for different causes of liver fibrosis and produce a standardized system for evaluating different pathologies using specialized algorithms.
Methods for quantifying the CPA and HYP content, which are also quantitative approaches for evaluating the collagen levels in the liver, were developed to obtain more accuracy and objectivity in the quantification of fibrosis. 22 Furthermore, we compared the performance of these 11 shared parameters with the CPA and HYP content. SHG imaging might improve the issues listed above, and the 11 shared parameters exhibited similar performance to CPA in the CCl 4 mice and TAA rat models and superior performance to CPA in the TAA mice and BDL rats. Moreover, the 11 shared parameters exhibited similar performance to the HYP content in the BDL rats and superior performance to the HYP content in the TAA rats, TAA mice, and CCl 4 mice. Collectively, these results suggest that the 11 shared parameters might replace the Ishak score, and the CPA or HYP content for evaluating liver fibrosis in the four different liver fibrosis models.
Histological staging is a fundamental concept included in our automated evaluation system, but the progression of fibrosis at different time points after modeling should also be considered when evaluating liver fibrosis. Therefore, based on their trends with respect to the different time points after modeling and AUC analyses, model-specific parameters were selected and shown to identify the differences among all time points in the four different fibrosis models with high AUC accuracy. These model-specific parameters, which mainly focus on string collagen in the TAA model, portal collagen in the CCl 4 model, and aggregated collagen in the BDL model, may be related to the specific collagen distribution patterns in the different models. Furthermore, the AUC values of the model-specific parameters were maintained at higher values than CPA in the TAA rats and mouse models and were similar to the CPA in the CCl 4 mice and BDL rat models. Similarly, the model-specific parameters achieved similar performance as the HYP content in the BDL rats and superior performance to the HYP content in the TAA rats, TAA mice, and CCl 4 mice. Thus, we showed that the model-specific parameters can potentially differentiate fibrosis at different time points in four different liver fibrosis models.
We combined the shared and model-specific parameters in the automated evaluation system. The system standardizes the measurements, is highly quantitative, and provides a unique method that precisely reflects the fibrosis levels independent of the operators, experimental conditions, or the tissue of origin. A recent study reported significant disparities in the fibrosis scores between observers using the Metavir or Ishak system, which increased between junior and qualified, senior academic pathologists. 23 The level of experience (specialization, duration, and location of practice) seemed to have a greater influence on the variability of Metavir or Ishak scores than the characteristics of the section itself. Although the CPA measurement generally detects fibrosis, the biochemical specificity of the staining methods is poor or even unknown. 24 The methods used to detect the HYP content are also complicated. The automated evaluation system, which avoids these drawbacks and recognizes the different fibrosis progression patterns in different animal models, potentially allows SHG/TPEF microscopy to be applied to diagnosis and the predictions of disease complications.
Although the automated evaluation system is very precise and highly reproducible, it deserves further commentary. The amount of fibrosis, regardless of whether it is evaluated using fibrillar collagen, is only a part of the deleterious process that leads to cirrhosis. Architectural changes, vascular shunts, and liver cell regeneration are among the other associated features that might have a significant influence on the natural progression of liver injury. These features are also evaluated when pathologists score injured tissues; however, these lesions are not considered by the automated evaluation system. Therefore, these 11 shared parameters are best used for investigating the fibrosis progression/regression patterns, but are not ideal for assessing cirrhosis.
Using SHG/TPEF imaging, this study reveals that the automated evaluation system, which combined 11 shared parameters that correlated with the Ishak stage and modelspecific parameters that differentiated different time points, may be useful for specifically, accurately, and quantitatively monitoring liver fibrosis in different animal models. Importantly, this method may greatly contribute to evaluations of experimental treatments in rodent models for which it is difficult to score fibrosis, because of the absence of welldefined scores, such as the Ishak staging and CPA evaluation systems. Undeniably, the automated evaluation system offers a reliable method that appreciably improves liver fibrosis assessments, and we anticipate that the automated evaluation system based on SHG/TPEF will be applied to assess the efficacy of antifibrotic drugs in the near future.
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